| Dr James Franklin Scheidler Ii, MD | |
|
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
| (304) 293-2346 | |
| Not Available |
| Full Name | Dr James Franklin Scheidler Ii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 1 Medical Center Dr, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093246761 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
The Israeli immunologist and cancer researcher Professor Yehudit Bergman of the Hebrew University of Jerusalem, Israel, has been honored with the Helmholtz International Fellow Award for her excellent research. In a prize ceremony at the MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany, MDC's interim director Professor Thomas Sommer presented the certificate to her on Thursday, June 18th, 2015.
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma.
According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
› Verified 7 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
The Israeli immunologist and cancer researcher Professor Yehudit Bergman of the Hebrew University of Jerusalem, Israel, has been honored with the Helmholtz International Fellow Award for her excellent research. In a prize ceremony at the MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany, MDC's interim director Professor Thomas Sommer presented the certificate to her on Thursday, June 18th, 2015.
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma.
According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
› Verified 7 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
The Israeli immunologist and cancer researcher Professor Yehudit Bergman of the Hebrew University of Jerusalem, Israel, has been honored with the Helmholtz International Fellow Award for her excellent research. In a prize ceremony at the MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany, MDC's interim director Professor Thomas Sommer presented the certificate to her on Thursday, June 18th, 2015.
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma.
According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
› Verified 7 days ago
| Entity Name | Wetzel County Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518590033 PECOS PAC ID: 4284065400 Enrollment ID: O20200520000593 |
News Archive
The Israeli immunologist and cancer researcher Professor Yehudit Bergman of the Hebrew University of Jerusalem, Israel, has been honored with the Helmholtz International Fellow Award for her excellent research. In a prize ceremony at the MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany, MDC's interim director Professor Thomas Sommer presented the certificate to her on Thursday, June 18th, 2015.
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma.
According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Franklin Scheidler Ii, MD Po Box 9149, Morgantown, WV 26506-9149 Ph: (304) 293-2346 | Dr James Franklin Scheidler Ii, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (304) 293-2346 |
News Archive
The Israeli immunologist and cancer researcher Professor Yehudit Bergman of the Hebrew University of Jerusalem, Israel, has been honored with the Helmholtz International Fellow Award for her excellent research. In a prize ceremony at the MDC Max Delbrück Center for Molecular Medicine in the Helmholtz Association in Berlin, Germany, MDC's interim director Professor Thomas Sommer presented the certificate to her on Thursday, June 18th, 2015.
Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal hormone therapy may actually lower the risk of B-cell non-Hodgkin lymphoma.
According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
› Verified 7 days ago
Dr. Nicole Lee Dorinzi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-216-0980 | |
Kevin J Blankenship, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 63 Wharf St, Suite 100, Morgantown, WV 26501 Phone: 304-291-3627 Fax: 304-598-3630 | |
Dr. Joseph Michael Hartzog, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Venture Dr, Morgantown, WV 26508 Phone: 304-291-5533 Fax: 304-291-5548 | |
Dr. Christopher Edwards, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1200 | |
Dr. John Harold Marsh, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Emergency Department, Morgantown, WV 26505 Phone: 304-598-1200 | |
Matthew Kersteter, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Po 9149, Morgantown, WV 26506 Phone: 304-293-7215 Fax: 304-293-6702 | |
Dr. Jack F Ditty Iii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Stadium Drive, Morgantown, WV 26505 Phone: 304-598-4000 Fax: 304-293-6963 |